Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells. [electronic resource]
- International journal of molecular sciences Jan 2017
Publication Type: Journal Article
1422-0067
10.3390/ijms18020271 doi
Adult Animals Dimethyl Fumarate--pharmacology Down-Regulation--drug effects Female Graft vs Host Disease--immunology Humans Lymphocyte Activation--drug effects Male Mice Middle Aged Multiple Sclerosis--drug therapy Receptors, Interleukin-6--metabolism Spleen--pathology T-Lymphocytes, Regulatory--drug effects Young Adult